|
(b)(4) date sent to fda: 04/15/2021 this report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc, or its employees that the report constitutes an admission that the product, ethicon inc or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Additional information: d9, h3, h4, h6 h3 analysis summary: the product was returned incomplete to ethicon inc for evaluation.Visual analysis of the returned sample determined that an empty opened overwrap of product code epm8743 was received for evaluation.Needle or suture was not returned.If additional information is made available, the investigation will be updated as applicable.A manufacturing record evaluation was performed for the finished device batch pgb598, epm874319 and no non-conformances were identified.Events reported in 2210968-2021-02323, 2210968-2021-02324, 2210968-2021-02325 (b)(4) date sent to fda: 04/15/2021 this report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc, or its employees that the report constitutes an admission that the product, ethicon inc or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|